131 related articles for article (PubMed ID: 31172920)
21. Screening for spondyloarthritis in patients with inflammatory bowel diseases.
Ottaviani S; Tréton X; Forien M; Coralli R; Dauchez A; Stefanescu C; Pelletier AL; Becheur H; Ebstein E; Bouhnik Y; Dieudé P
Rheumatol Int; 2023 Jan; 43(1):109-117. PubMed ID: 36161358
[TBL] [Abstract][Full Text] [Related]
22. 2018 APLAR axial spondyloarthritis treatment recommendations.
Tam LS; Wei JC; Aggarwal A; Baek HJ; Cheung PP; Chiowchanwisawakit P; Dans L; Gu J; Hagino N; Kishimoto M; Reyes HM; Soroosh S; Stebbings S; Whittle S; Yeap SS; Lau CS
Int J Rheum Dis; 2019 Mar; 22(3):340-356. PubMed ID: 30816645
[TBL] [Abstract][Full Text] [Related]
23. Management of patients with inflammatory bowel disease and spondyloarthritis.
Pouillon L; Bossuyt P; Vanderstukken J; Moulin D; Netter P; Danese S; Jouzeau JY; Loeuille D; Peyrin-Biroulet L
Expert Rev Clin Pharmacol; 2017 Dec; 10(12):1363-1374. PubMed ID: 28879780
[TBL] [Abstract][Full Text] [Related]
24. Clinical and sonographic discrimination between fibromyalgia and spondyloarthopathy in inflammatory bowel disease with musculoskeletal pain.
Martinis F; Tinazzi I; Bertolini E; Citriniti G; Variola A; Geccherle A; Marchetta A; McGonagle D; Macchioni P
Rheumatology (Oxford); 2020 Oct; 59(10):2857-2863. PubMed ID: 32068873
[TBL] [Abstract][Full Text] [Related]
25. Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis.
Triggianese P; Conigliaro P; Chimenti MS; Biancone L; Monteleone G; Perricone R; Monteleone I
Clin Exp Rheumatol; 2016; 34(6):1085-1093. PubMed ID: 27782868
[TBL] [Abstract][Full Text] [Related]
26. The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study.
Lie E; Kristensen LE; Forsblad-d'Elia H; Zverkova-Sandström T; Askling J; Jacobsson LT;
Ann Rheum Dis; 2015 Jun; 74(6):970-8. PubMed ID: 25710471
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-1 associations in inflammatory bowel disease and the enteropathic seronegative spondylarthritis.
Vounotrypidis P; Kouklakis G; Anagnostopoulos K; Zezos P; Polychronidis A; Maltezos E; Efremidou E; Pitiakoudis M; Lyratzopoulos N
Auto Immun Highlights; 2013 Dec; 4(3):87-94. PubMed ID: 26000147
[TBL] [Abstract][Full Text] [Related]
28. [Immune-mediated inflammatory diseases in patients with inflammatory bowel disease. Baseline data from the Aquiles study].
Marín-Jiménez I; García Sánchez V; Gisbert JP; Lázaro Pérez Calle J; Luján M; Gordillo Ábalos J; Tabernero S; Juliá B; Romero C; Cea-Calvo L; García-Vicuña R; Vanaclocha F
Gastroenterol Hepatol; 2014 Nov; 37(9):495-502. PubMed ID: 24717523
[TBL] [Abstract][Full Text] [Related]
29. Safety, efficacy and immunogenicity of switching from innovator to biosimilar infliximab in patients with spondyloarthritis: a 6-month real-life observational study.
Benucci M; Gobbi FL; Bandinelli F; Damiani A; Infantino M; Grossi V; Manfredi M; Parisi S; Fusaro E; Batticciotto A; Sarzi-Puttini P; Atzeni F; Meacci F
Immunol Res; 2017 Feb; 65(1):419-422. PubMed ID: 27449503
[TBL] [Abstract][Full Text] [Related]
30. Musculoskeletal manifestations in a Portuguese cohort of 235 inflammatory bowel disease patients.
Fernandes BM; Rosa-Gonçalves D; Magro F; Costa L; Bernardes M
ARP Rheumatol; 2022; 1(2):137-141. PubMed ID: 35810372
[TBL] [Abstract][Full Text] [Related]
31. Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings.
Iannone F; Salaffi F; Fornaro M; Di Carlo M; Gentileschi S; Cantarini L; Lopalco G
Eur J Clin Invest; 2018 Nov; 48(11):e13013. PubMed ID: 30079593
[TBL] [Abstract][Full Text] [Related]
32. Two years follow-up of golimumab treatment in refractory enteropathic spondyloarthritis patients with Crohn disease: A STROBE-compliant study.
Conigliaro P; Chimenti MS; Triggianese P; D'Antonio A; Sena G; Alfieri N; Biancone L; Perricone R
Medicine (Baltimore); 2021 Mar; 100(12):e25122. PubMed ID: 33761677
[TBL] [Abstract][Full Text] [Related]
33. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory Bowel Disease Environmental Risk Factors: A Population-Based Case-Control Study of Middle Eastern Migration to Australia.
Ko Y; Kariyawasam V; Karnib M; Butcher R; Samuel D; Alrubaie A; Rahme N; McDonald C; Cowlishaw J; Katelaris P; Barr G; Jones B; Connor S; Paven G; Chapman G; Park G; Gearry R; Leong RW;
Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1453-63.e1. PubMed ID: 25771246
[TBL] [Abstract][Full Text] [Related]
35. ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors.
Pedersen SJ; Sørensen IJ; Garnero P; Johansen JS; Madsen OR; Tvede N; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen K; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Skjødt T; Lambert R; Hansen A; Østergaard M
Ann Rheum Dis; 2011 Aug; 70(8):1375-81. PubMed ID: 21551511
[TBL] [Abstract][Full Text] [Related]
36. EQ-5D utility, response and drug survival in rheumatoid arthritis patients on biologic monotherapy: A prospective observational study of patients registered in the south Swedish SSATG registry.
Jørgensen TS; Turesson C; Kapetanovic M; Englund M; Turkiewicz A; Christensen R; Bliddal H; Geborek P; Kristensen LE
PLoS One; 2017; 12(2):e0169946. PubMed ID: 28151971
[TBL] [Abstract][Full Text] [Related]
37. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific.
Ng SC; Tang W; Leong RW; Chen M; Ko Y; Studd C; Niewiadomski O; Bell S; Kamm MA; de Silva HJ; Kasturiratne A; Senanayake YU; Ooi CJ; Ling KL; Ong D; Goh KL; Hilmi I; Ouyang Q; Wang YF; Hu P; Zhu Z; Zeng Z; Wu K; Wang X; Xia B; Li J; Pisespongsa P; Manatsathit S; Aniwan S; Simadibrata M; Abdullah M; Tsang SW; Wong TC; Hui AJ; Chow CM; Yu HH; Li MF; Ng KK; Ching J; Wu JC; Chan FK; Sung JJ;
Gut; 2015 Jul; 64(7):1063-71. PubMed ID: 25217388
[TBL] [Abstract][Full Text] [Related]
38. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
39. Fibromyalgia in Spondyloarthritis: Effect on Disease Activity Assessment in Clinical Practice.
Wach J; Letroublon MC; Coury F; Tebib JG
J Rheumatol; 2016 Nov; 43(11):2056-2063. PubMed ID: 27633820
[TBL] [Abstract][Full Text] [Related]
40. The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies.
de Lima-Karagiannis A; Zelinkova-Detkova Z; van der Woude CJ
Am J Gastroenterol; 2016 Sep; 111(9):1305-12. PubMed ID: 27349339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
